Analysis of interactions between serotonin and gabapentin or adenosine in the spinal cord of rats

Pharmacology

Volumn 74, Issue 1, 2005, Pages 15-22

  Yoon, Myung Ha ^a   Choi II, Jeong ^a   Park, Heon Chang ^a   Bae, Hong Beom ^a   Jeong, Seong Wook ^a   Jeong, Chang Young ^a  

^a Chonnam National University   (South Korea)

Author keywords

Adenosine; Antinociception; Drug interaction; Formalin test; Gabapentin; Serotonin; Spinal cord

Indexed keywords

ADENOSINE; FORMALDEHYDE; GABAPENTIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CATHETER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; DRUG SCREENING; HINDLIMB; INJECTION; MALE; NOCICEPTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL PAIN; SUBARACHNOID SPACE;

ADENOSINE; AMINES; ANALGESICS; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, SPINAL; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPINAL CORD;

EID: 17844373846     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082996     Document Type: Article

References (30)

1. Furst S: Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999;48:129-141.
2. Bardin L, Bardin M, Lavarenne J, Eschalier A: Effect of intrathecal serotonin on nociception in rats: Influence of the pain test used. Exp Brain Res 1997;113:81-87.
3. Bardin L, Lavarenne J, Eschalier A: Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000;86:11-18.
4. Nadeson R, Goodchild CS: Antinociceptive role of 5-HT1A receptors in rat spinal cord. Br J Anaesth 2002;88:679-684.
5. Sasaki M, Ishizaki K, Obata H, Goto F: Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001;424:45-52.
6. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP: International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
7. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29:233-249.
8. Yoon MH, Yaksh TL: The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg 1999;89:434-439.
9. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L: Evaluation of gabapentin and S-(+)-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 1997;282:1242-1246.
10. Reeve AJ, Dickenson AH: The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurones in the anaesthetized rat. Br J Pharmacol 1995;116:2221-2228.
11. Poon A, Sawynok J: Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain 1998;74:235-245.
12. Choca JI, Green RD, Proudfit HK: Adenosine A1 and A2 receptors of the substantia gelatinosa are located predominantly on intrinsic neurons: an autoradiography study. J Pharmacol Exp Ther 1988;247:757-764.
13. Sjölund KF, Sollevi A, Segerdahl M, Lundeberg T: Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats. Anesth Analg 1997;85:627-632.
14. Chiari AI, Eisenach JC: Intrathecal adenosine: Interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity. Anesthesiology 1999;90:1413-1421.
15. Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-1036.
16. Nishiyama T: Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur J Pharmacol 2000;395:203-210.
17. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs, ed 2. New York, Springer, 1987, pp 1-95.
18. Yaksh TL: Preclinical models of nociception; in Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ (eds): Anesthesia: Biologic Foundations. Philadelphia, Lippincott-Raven, 1997, pp 685-718.
19. Yaksh TL, Wilson PR: Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 1979;208:446-453.
20. Fields HL, Heinricher MM, Mason P: Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991;14:219-245.
21. Kaneko M, Mestre C, Sanchez EH, Hammond DL: Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of fos-like immunoreactivity in the spinal cord of the rat. J Pharmocol Exp Ther 2000;292:743-751.
22. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ: The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 1997;324:153-160.
23. Sawynok J: Purines in pain management. Curr Opin CPNS Invest Drugs 1999;1:27-38.
24. Santicioli P, Del Bianco E, Tramontana M, Maggi CA: Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord. Neurosci Lett 1992;144:211-214.
25. Salter MW, De Koninck Y, Henry JL: Physiological roles for adenosine and ATP in synaptic transmission in the spinal dorsal horn. Prog Neurobiol 1993;41:125-156.
26. Li J, Perl ER: Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol 1994;72:1611-1621.
27. Berenbaum MC: What is synergy? Pharmacol Rev 1989;41:93-141.
28. Malmberg AB, Yaksh TL: Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993;79:270-281.
29. Sawynok J, Reid A: Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res 1996;73:63-68.
30. Poon A, Sawynok J: Antinociception by adenosine analogs and an adenosine kinase inhibitor: Dependence on formalin concentration. Eur J Pharmacol 1995;286:177-184.